Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H11F6N3O |
Molecular Weight | 423.3113 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1)C2=C3N=C(C=C(N3N=C2C4=CC=CC=C4)C(F)(F)F)C(F)(F)F
InChI
InChIKey=AEZPAUSGTAHLOQ-UHFFFAOYSA-N
InChI=1S/C20H11F6N3O/c21-19(22,23)14-10-15(20(24,25)26)29-18(27-14)16(11-6-8-13(30)9-7-11)17(28-29)12-4-2-1-3-5-12/h1-10,30H
Molecular Formula | C20H11F6N3O |
Molecular Weight | 423.3113 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q92731|||O75584 Gene ID: 2100.0 Gene Symbol: ESR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15537344 |
0.05 nM [Kd] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:07:11 GMT 2023
by
admin
on
Sat Dec 16 19:07:11 GMT 2023
|
Record UNII |
NN82CVN36N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11201035
Created by
admin on Sat Dec 16 19:07:11 GMT 2023 , Edited by admin on Sat Dec 16 19:07:11 GMT 2023
|
PRIMARY | |||
|
NN82CVN36N
Created by
admin on Sat Dec 16 19:07:11 GMT 2023 , Edited by admin on Sat Dec 16 19:07:11 GMT 2023
|
PRIMARY | |||
|
805239-56-9
Created by
admin on Sat Dec 16 19:07:11 GMT 2023 , Edited by admin on Sat Dec 16 19:07:11 GMT 2023
|
PRIMARY | |||
|
DTXSID10458573
Created by
admin on Sat Dec 16 19:07:11 GMT 2023 , Edited by admin on Sat Dec 16 19:07:11 GMT 2023
|
PRIMARY | |||
|
PHTPP
Created by
admin on Sat Dec 16 19:07:11 GMT 2023 , Edited by admin on Sat Dec 16 19:07:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
|
||
|
TARGET -> INHIBITOR |
ANTAGONIST
|